Effectiveness of Sealants and Fluoride Varnish in Caries Prevention in Children With Autism Spectrum Disorders
NCT ID: NCT05146479
Last Updated: 2021-12-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
232 participants
OBSERVATIONAL
2006-01-01
2021-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Patients with at least 10-year follow-up and ASDs are recruited and allocated to two cohort according to the strategy adopted for prevention of caries in first permanent molars: FA group (only fluoride varnishes) and FA+S group (sealants together with fluoride varnishes).
Caries incidence and sealants retention after the follow-up period are recorded. Demographic and clinical characteristics of patients at first dental visit are also recorded (age, level of cooperation, presence of systemic diseases other than ASDs, caries severity) to evaluate if they play a potential protective and/or risk factors for caries development.
Logistic and multivariate analysis are run to evaluate caries incidence and retention rate of sealants in first permanent molars over a period of at least 10 years.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Fluoride varnish (FA group)
Application of 5% NaF varnish onto first permanent molars
No interventions assigned to this group
Fluoride varnish + dental sealant (FA+S group)
Application of 5% NaF varnish plus pit and fissure sealant onto first permanent molars
Fluoride varnish and pit and fissure sealants onto first permanent molars
Quarterly application of fluoride varnish. Application of pit and fissure sealant, and replacements if necessary.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Fluoride varnish and pit and fissure sealants onto first permanent molars
Quarterly application of fluoride varnish. Application of pit and fissure sealant, and replacements if necessary.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* age less than 14 years
* written declaration of informed consent signed by parents/guardians
Exclusion Criteria
* missing five or more dental check-ups over the follow-up period
* oral or dental care provided in sedation or general anesthesia
* follow-up less than 15 years
3 Years
14 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Milan
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Maria Grazia Cagetti
Prof. Maria Grazia Cagetti
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Maria Grazia MG Cagetti, Prof
Role: STUDY_CHAIR
University of Milan
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dental Clinic San Paolo Hospital
Milan, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0000546
Identifier Type: -
Identifier Source: org_study_id